当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
Ishaleku D, Umeh EU, Amali O, Gberikon GM
The emergence of drug resistant strains of Salmonella typhi and paratyphi has become the most challenging aspects of typhoid fever treatment due to resistance to the conventional antibiotic therapy. The objective of this study was to determine the prevalence and antibiotic susceptibility of Salmonella species among typhoid fever patients. A total of 400 stool samples were collected, processed and identified by standard microbiological method and biochemical tests. Antibiotic susceptibility was determined by disk diffusion method using 8 antibiotics. A total of 196(49.0%) Salmonella species were isolated. Of this, 78 (19.0%) and 118 (29.5%) were Salmonella typhi and Salmonella paratyphi respectively. The antibiotic susceptibility of Salmonella isolates in the study showed a high susceptibility of 85.9% for S. typhi and 86.4% for S. paratyphi to Chloramphenicol. All S. typhi isolates showed a low
susceptibility of 20.5% to Amoxicillin, 14.1% to Amoxicillin/clavulinic acid, and 33.3% to ceftriaxone. 85.2%, 87.4% and 6.9% to Ciprofloxacin, Gentamycin and Tetracycline respectively. Salmonella paratyphi isolates on the other hand also showed higher susceptibility of 89.1%, 83.6%, 80.9%, 79.1% to Amikacin, Ciprofloxacin, Ceftriaxone, Gentamycin and lower susceptibility of 23.6%, 36.4% and 20.9% to Amoxicillin, Amoxicillin/clavulinic acid and Tetracycline respectively. The increasing susceptibility of Salmonella species to Chloramphenicol in this study therefore is a revelation that suggests the necessity for continuous surveillance of cases and re-evaluation of Chloramphenicol therapy in Salmonella infection in Nasarawa South and the state as a whole.